Use of a Combination of Class III and Class Ic Antiarrhythmic Agents in Patients with Electrical Storm

Study Objective. To determine the efficacy of the combination of class III and class Ic antiarrhythmic agents in suppressing an electrical storm in patients with and without a transvenous implantable cardioverter‐defibrillator (ICD).

[1]  Dan M. Roden,et al.  ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines , 2006 .

[2]  A. Mahajan,et al.  Use of thoracic epidural anesthesia for management of electrical storm: a case report. , 2005, Heart rhythm.

[3]  Antonio Berruezo,et al.  Nonsurgical transthoracic epicardial radiofrequency ablation: an alternative in incessant ventricular tachycardia. , 2003, Journal of the American College of Cardiology.

[4]  D. Wyse,et al.  Electrical Storm Presages Nonsudden Death: The Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial , 2001, Circulation.

[5]  C. Sticherling,et al.  Electrical storm in patients with transvenous implantable cardioverter-defibrillators: incidence, management and prognostic implications. , 1998, Journal of the American College of Cardiology.

[6]  K. Cao,et al.  Catheter ablation of incessant ventricular tachycardia: acute and long-term results. , 1996, European heart journal.

[7]  J. Fisher,et al.  Comparison and frequency of ventricular arrhythmias after defibrillator implantation by thoracotomy versus nonthoracotomy approaches. , 1994, The American journal of cardiology.

[8]  M. Eichelbaum,et al.  Variable disposition kinetics and electrocardiographic effects of flecainide during repeated dosing in humans: Contribution of genetic factors, dose‐dependent clearance, and interaction with amiodarone , 1994, Clinical pharmacology and therapeutics.

[9]  B. Lüderitz,et al.  Efficacy and Safety of Combination Therapy with Amiodarone and Type I Agents for Treatment of Inducible Ventricular Tachycardia , 1993, Pacing and clinical electrophysiology : PACE.

[10]  H L Greene,et al.  Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. , 1991, The New England journal of medicine.

[11]  R. Hariman,et al.  Long-term follow-up in patients with incessant ventricular tachycardia. , 1990, The American journal of cardiology.

[12]  J. Fisher,et al.  Combination of disopyramide and mexiletine for better tolerance and additive effects for treatment of ventricular arrhythmias. , 1989, Journal of the American College of Cardiology.

[13]  J. Fisher,et al.  Combination of tocainide and quinidine for better tolerance and additive effects in patients with coronary artery disease. , 1987, Journal of the American College of Cardiology.

[14]  J. Fisher,et al.  Electrophysiologic effects and clinical efficacy of mexiletine used alone or in combination with class IA agents for refractory recurrent ventricular tachycardias or ventricular fibrillation. , 1986, The American journal of cardiology.

[15]  J. Fisher,et al.  Combination of procainamide and quinidine for better tolerance and additive effects for ventricular arrhythmias. , 1985, The American journal of cardiology.

[16]  C. Schmitt,et al.  Rescue ablation of electrical storm in patients with ischemic cardiomyopathy: a potential-guided ablation approach by modifying substrate of intractable, unmappable ventricular tachycardias. , 2005, Heart rhythm.

[17]  J. Fisher,et al.  Value of Holter monitoring in predicting long-term efficacy and inefficacy of amiodarone used alone and in combination with class 1A antiarrhythmic agents in patients with ventricular tachycardia. , 1987, Journal of the American College of Cardiology.

[18]  D. Zipes,et al.  Effect of drugs on conduction delay and incidence of ventricular arrhythmias induced by acute coronary occlusion in dogs. , 1977, The American journal of cardiology.